Incyte Biosciences International Sàrl

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Incyte Biosciences International Sàrl sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials none currently recruiting 5 completed early-phase tilt upper quartile by trial count

Incyte Biosciences International Sàrl: 7 sponsored US clinical trials, none currently recruiting.

Incyte Biosciences International Sàrl sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 0 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Head and Neck Cancer, with 1 trials.

Upper-quartile sponsor footprint

Incyte Biosciences International Sàrl sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

7 total, page 1 of 1

ACTIVE NOT RECRUITING Phase 2

Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT05287113
COMPLETED Phase 1

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

NCT03538028
TERMINATED Phase 1

INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

NCT03277352
COMPLETED Phase 1

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

NCT03241173
COMPLETED Phase 1

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

NCT03126110
COMPLETED Phase 1

A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors

NCT02923349
COMPLETED Phase 1

A Study of INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors

NCT02697591

Phase Distribution

PhaseTrial count
Phase 1 6
Phase 2 1

Therapeutic Areas

Head and Neck Cancer 1

How the Incyte Biosciences International Sàrl early-phase archive is shaped

7 indexed studies, none listed as recruiting (0% open); 5 completed (71%).

Phase mix: 0 late (III/IV) vs 7 early (I/II) (early-phase heavy).

Top condition: Head and Neck Cancer (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Incyte Biosciences International Sàrl: archived-pipeline peers nationwide

Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Incyte Biosciences International Sàrl sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share Incyte Biosciences International Sàrl3M4Life Research89bioAbbott Diagnostics Division10xBio22nd Century Group23andMe3-C Institute for Social Development
Incyte Biosciences International Sàrl sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Incyte Biosciences International Sàrl sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Incyte Biosciences International Sàrl page

7 registered trials is a research-attention snapshot, not an endorsement of Incyte Biosciences International Sàrl or any single study.

  • None of Incyte Biosciences International Sàrl's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Head and Neck Cancer is the condition Incyte Biosciences International Sàrl studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Head and Neck Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Incyte Biosciences International Sàrl pipeline card: 7 registered trials from official public datasets.Report a data error.